Navigation Links
Northfield Laboratories Investor Update

quate supplies of raw materials and to manufacture PolyHeme in commercial quantities, our ability to market PolyHeme successfully, the possibility that competitors will develop products that will render PolyHeme obsolete or non-competitive, our ability to protect our intellectual property rights, the outcome of certain governmental inquiries and purported class action lawsuit as described in our most recently filed annual report on Form 10-K and quarterly report on Form 10-Q, the possibility that we may be subject to product liability claims and other legal actions, our dependency on a limited number of key personnel, the uncertainty of third party reimbursement for our product and other risks and uncertainties described from time to time in our periodic reports filed with the Securities and Exchange Commission, including our most recently filed annual report on Form 10-K and quarterly report on Form 10-Q. These forward-looking statements speak only as of the date of this press release. We do not undertake any obligation to update or publicly release any revisions to forward-looking statements to reflect events, circumstances or changes in expectations after the time such statement is made. All subsequent written and oral forward-looking statements attributable to Northfield or any person acting on our behalf are qualified by this cautionary statement.

Contact

Northfield Laboratories Inc.
Sophia H. Twaddell, 847-864-3500
Vice President, Corporate Communications
stwaddell@northfieldlabs.com
or
Fleishman-Hillard
Tom Laughran, 312-751-3519
tom.laughran@fleishman.com


'"/>




Page: 1 2

Related medicine technology :

1. Northfield Laboratories Reports Results of Pivotal Phase III Trauma Study
2. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
3. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study for Milnacipran as a Treatment for Fibromyalgia Syndrome
4. Columbia Laboratories Reports Preliminary Findings from the Ongoing Data Analysis of the Phase III Clinical Study of PROCHIEVE 8% (progesterone gel) to Prevent Preterm Birth
5. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
6. Review of Nexavar Data Presented at ASCO 2007- Investor Conference Call on June 4, 2007
7. Acorda Therapeutics to Host Analyst and Investor Reception
8. Isis Pharmaceuticals Announces Its Participation at the Upcoming ACC 56th Annual Scientific Session in New Orleans and Its Live Analyst/Investor Webcast Presentation
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Avexas Apricitabine Clinical Trial Update
11. Avalon Updates the AVN944 Phase I Hematologic Malignancies Trial
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Northfield Laboratories Investor Update
(Date:7/23/2014)... ANGELES , July 23, 2014  Researchers from ... with calcium elevates calcium levels too high, ... among other health problems. Women close to ... and vitamin D to prevent diseases such as osteoporosis, ... would recommend that women determine how much calcium they ...
(Date:7/23/2014)... July 23, 2014  Lightlake Therapeutics Inc. ("Lightlake") ... based on its expertise in opioid antagonists, announced ... drug application ("IND") with respect to its naloxone-based ... today that it has received an additional commitment ... part of the National Institutes of Health ("NIH"), ...
(Date:7/23/2014)... , July 23, 2014  Mevesi Inc. would ... Media. This integration provides pharmacies with the ability ... and prospective patients. Mevesi,s solutions ... consumer data to define target marketing campaigns. This ... capabilities available within the Digital Marketing, Population Management, ...
Breaking Medicine Technology:Women Taking Too Much Calcium Create Health Risk 2Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 2Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 3Mevesi Enhances Solutions with Variable Print Media Capabilities! 2
... Inc. (ReGen), manufacturer of the popular and successful Menaflex Collagen ... (FDA) offer of a hearing under 21 CFR Part 16 ... the device. According to ReGen Chair and CEO ... FDA over the past six years makes it clear that ...
... 2011 Terso Solutions, Inc. has expanded its line ... refrigerator that is well-suited for hospital and laboratory ... new refrigerator makes better use of space, reduces energy ... such as reagents, cardiovascular products, tissue samples, and orthopedic ...
Cached Medicine Technology:ReGen to FDA: 'Thanks, But No Thanks' 2ReGen to FDA: 'Thanks, But No Thanks' 3ReGen to FDA: 'Thanks, But No Thanks' 4Terso Solutions Launches New RFID-Enabled Refrigerator for Hospital and Laboratory Inventory Management 2
(Date:7/24/2014)... management experts at FACE Skincare Medical Wellness are excited ... 3-in-1 Super Facial, specifically designed to increase hydration and ... leaving skin looking radiant. FACE is one of the ... Israel, and the first and only medical spa ... , This innovative treatment uses the unique Oxygeneo™ applicator, ...
(Date:7/24/2014)... Follow us on LinkedIn – ... polyols, is driven by increasing demand from pharmaceuticals, food ... growing awareness over the benefits of consuming alternate sweeteners, ... of the key factors driving growth in the sugar ... the health benefits of sweeteners, consumer adoption is on ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 Professional Healthcare at ... announce that Karen Schulkin, a nurse with the company’s Pleasant ... Top 10 Finalist for the 2014 Home Care & Hospice ... for Home Care & Hospice (NAHC). , Annually, NAHC ... and the public to help choose a top home care ...
(Date:7/24/2014)... Maintaining proper oral hygiene is just as important for dogs ... recent years, many different products have become available to dog ... Royal Flush Havanese shares with readers some helpful ... choosing the top products that are the most effective. , ... a dog’s mouth, causing bad breath. This can also lead ...
(Date:7/23/2014)... The beauty products industry is expected ... 2020, according to recent news reports. Creams and oils ... in the U.S. and the CherryNews.com company is now ... is now reviewed at http://cherrynews.com/best-nourishing-eye-serum . , This ... experienced shopper to compare the different brands offered from ...
Breaking Medicine News(10 mins):Health News:FACE Skincare Medical Wellness Debuts Exclusive 3-in-1 Facial Treatment in Michigan 2Health News:Rising Incidence of Diabetes and Obesity Drives the Global Sugar Alcohols Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Rising Incidence of Diabetes and Obesity Drives the Global Sugar Alcohols Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Professional Healthcare at Home’s Karen Schulkin Named Top 10 Finalist Representing California for 2014 Home Care & Hospice Nurse of the Year 2Health News:Professional Healthcare at Home’s Karen Schulkin Named Top 10 Finalist Representing California for 2014 Home Care & Hospice Nurse of the Year 3Health News:Royal Flush Havanese Reviews Tips on Proper Dental Care For Canines 2Health News:Royal Flush Havanese Reviews Tips on Proper Dental Care For Canines 3Health News:Best Wrinkle Cream Under $100 Reviewed at Top News Website Online 2
... mutations in the p53 tumor-suppressor gene, suggesting the critical ... against cancer. Similarly, roughly 95 percent of cancer-causing mutations ... domain, pointing to this region of the p53 protein ... ,Clearly, a detailed view of the p53 protein in ...
... Victoria Metcalf is out to delve into the Antarctic ... the genetic filter technology// to understand how fish actually ... of the existing connection between fat metabolism and heart ... fat for fuel, unlike humans who get the energy ...
... Health (MOH) says that Singapore will soon conduct a ... Readiness.// , More than 1,000 personnel from ... of Education, the Civil Aviation Authority of Singapore, Immigration ... in the exercise code-named SPARROWHAWK II. , ...
... loss of functions in Alzheimer's patients and found that ... executive ability// is the next to go. ... Clinic. The results of the study presented in the ... cognitive function starts to deteriorate in Alzheimer’s patients they ...
... to 23 students in a post-graduate course by the K ... ,"The division bench of Justice Y R Meena ... administration had not conducted the entrance tests and admission process ... Upadhaya, who argued the case on behalf of two students ...
... that many of the youths working in BPO firms ... ,The experts explained that working continually on ... of the youth. Dr Lim Li Ling, Deputy Director, ... Hospital, said, "Heavy food during night, skipping breakfast, eating ...
Cached Medicine News:Health News:DNA-bound p53 Tumor Suppressor Protein Structure Determined 2
The upper body blanket covers the upper torso, arms, neck, and head of the patient....
... air to the patient by way of ... 10C. Cooling the body below the normal ... a therapeutic tool, particularly for the control ... widely used as a treatment for traumatic ...
Blood grouping tubes are available in two formulations, ACD-A, ACD-B or with a CPDA solution. Blood grouping tubes are for blood grouping determinations and also for cell preservation....
BD Vacutainer® Specialty Tubes - Other - Glass...
Medicine Products: